Overview
Denali was founded by scientists, drug developers and investors who share the vision that recent scientific insights in genetics, biology and translational medicine offer an unprecedented opportunity to discover and develop effective medicines for patients suffering from neurodegenerative disease.
Their website can be found at this link.
NASDAQ: DNLI : Denali Therapeutics
News
-
05 Jan 2018 2 min read
Baillie Gifford-backed Denali secures Takeda as partner
Baillie Gifford-backed Denali secures Takeda as partner Baillie Gifford-backed US-biotech Denali Therapeutics has secured its first corporate out-licensing deal, just weeks after completing its Nasdaq IPO. Denali, which features in the Scottish Mortgage Investment Trust SMT portfolio, has signed a development deal with Takada covering three programmes for the treatment of Alzheimer’s disease and other neuro-degenerative diseases. […]
-
11 Dec 2017 2 min read
Scottish Mortgage to benefit from Denali IPO
Scottish Mortgage to benefit from Denali IPO – Baillie Gifford-managed Scottish Mortgage Investment Trust SMT looks set to receive a significant £85m windfall as a result of last week’s Nasdaq IPO of Denali Therapeutics, a US-based biotech in which it invested in 2016. Baillie Gifford was the lead investors in Denali’s $130m Series B financing round, investing […]
